Abstract
Features of both systemic lupus erythematosus and scleroderma developed in a young Chinese girl while on multiple anticonvulsant therapy. These were reversed after withdrawal of the drugs. Readministration of ethosuximide for control of epilepsy caused a relapse with predominant sclerodermatous features. These clinical signs again resolved after ethosuximide withdrawal.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alarcón-Segovia D. Drug-induced lupus syndromes. Mayo Clin Proc. 1969 Sep;44(9):664–681. [PubMed] [Google Scholar]
- HASERICK J. R. Modern concepts of systemic lupus erythematosus; a review of 126 cases. J Chronic Dis. 1955 Mar;1(3):317–334. doi: 10.1016/0021-9681(55)90040-0. [DOI] [PubMed] [Google Scholar]
- Livingston S., Rodriguez H., Greene C. A., Pauli L. L. Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy. JAMA. 1968 May 20;204(8):731–732. doi: 10.1001/jama.203.8.731. [DOI] [PubMed] [Google Scholar]
- Winkelmann R. K. Classification and pathogenesis of scleroderma. Mayo Clin Proc. 1971 Feb;46(2):83–91. [PubMed] [Google Scholar]